Difference between revisions of "ICRP Glossary"
Jump to navigation
Jump to search
| Line 275: | Line 275: | ||
*DD (see [[Doubling dose]]) | *DD (see [[Doubling dose]]) | ||
| + | |||
| + | *DDI, detector dose indicator (see [[Exposure index]]) | ||
*DIL (see [[Derived investigation level]]) | *DIL (see [[Derived investigation level]]) | ||
| Line 295: | Line 297: | ||
*[[Derived investigation level]] | *[[Derived investigation level]] | ||
| + | |||
| + | *Detector dose indicator (see [[Exposure index]]) | ||
| + | |||
| + | *[[Detector quantum efficiency]] | ||
*[[Deterministic effect]] | *[[Deterministic effect]] | ||
| Line 301: | Line 307: | ||
*[[Detriment-adjusted risk]] | *[[Detriment-adjusted risk]] | ||
| + | |||
| + | *[[Diagnostic reference level]] | ||
*[[Diastasis]] | *[[Diastasis]] | ||
| Line 321: | Line 329: | ||
*[[Distribution coefficient]] (''K<sub>d</sub>'') | *[[Distribution coefficient]] (''K<sub>d</sub>'') | ||
| + | |||
| + | *DLP (see [[Dose-length product]]) | ||
*[[DNA damage signalling]] | *[[DNA damage signalling]] | ||
| Line 359: | Line 369: | ||
*[[Dose rate effectiveness factor]] | *[[Dose rate effectiveness factor]] | ||
| + | |||
| + | *[[Dose-length product]] | ||
*[[Dose-threshold hypothesis]] | *[[Dose-threshold hypothesis]] | ||
| Line 369: | Line 381: | ||
*[[Doubling dose]] | *[[Doubling dose]] | ||
| + | |||
| + | *DQE (see [[Detector quantum efficiency]]) | ||
| + | |||
| + | *DRL (see [[Diagnostic reference level]]) | ||
| + | |||
| + | *[[DRL process]] | ||
| + | |||
| + | *[[DRL quantity]] | ||
| + | |||
| + | *[[DRL value]] | ||
*[[DS02]] | *[[DS02]] | ||
| Line 393: | Line 415: | ||
*[[Effective half-life]] | *[[Effective half-life]] | ||
| + | |||
| + | *EI (see [[Exposure index]]) | ||
*[[Electron-capture decay]] | *[[Electron-capture decay]] | ||
| Line 455: | Line 479: | ||
*[[Existing exposure situation]] | *[[Existing exposure situation]] | ||
| + | |||
| + | *[[Exogenous excretion]] | ||
*[[Expanded and aligned radiation field]] | *[[Expanded and aligned radiation field]] | ||
| Line 465: | Line 491: | ||
*[[Exposure (in the context of inhalation)]] | *[[Exposure (in the context of inhalation)]] | ||
| + | |||
| + | *[[Exposure index]] | ||
*[[Exposure pathway]] | *[[Exposure pathway]] | ||
Revision as of 15:24, 28 March 2021
The ICRP Glossary collects ICRP’s definitive explanations of terms for current use. Some entries include historical descriptions to help readers better understand the term in a particular context.
It is a living document, updated regularly.
Many ICRP publications feature their own glossaries including, for example, highly specialized terms relevant to that specific publication or helpful for a reader to have close at hand, or when introducing new terms to be added to the ICRP Glossary.
Although the ICRP Glossary is not a dictionary, terms already well covered in the Oxford English Dictionary are not included here unless further explanation is needed to understand the way in which these terms are used in ICRP publications.
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ... |
A
- Acute radiation sickness (see Acute radiation syndrome)
- ALI (see Annual limit on intake)
- AMAD (see Activity median aerodynamic diameter)
- Ambient dose equivalent, H*(10)
- ARS (see Acute radiation syndrome)
B
- BAT (see Best available techniques)
- Bcr/abl (see Breakpoint cluster region/abelson)
C
- CACA (see Cobblestone area forming cell assay)
- CAFC (see Cobblestone area forming cell assay)
- CBCT (see Cone beam computed tomography)
- Cobblestone area cell assay (see Cobblestone area forming cell assay)
D
- DAC (see Derived air concentration)
- DD (see Doubling dose)
- DDI, detector dose indicator (see Exposure index)
- DIL (see Derived investigation level)
- DDREF (see Dose and dose-rate effectiveness factor)
- Detector dose indicator (see Exposure index)
- Directional dose equivalent H’(d,Ω)
- DLP (see Dose-length product)
- Dose (of ionising radiation)
- DQE (see Detector quantum efficiency)
- DRL (see Diagnostic reference level)
E
- EAR (see Excess absolute risk)
- EI (see Exposure index)
- ELR (i.e. Excess Lifetime Risk, see Lifetime risk estimates)
- Endosteal tissue (see Endosteum)
- ERR (see Excess relative risk)
- Excess lifetime risk (see Lifetime risk estimates)
F
- Fluence, Φ
G
- Gray (Gy)
H
- HATM (see Human Alimentary Tract Model]
I
- Incidence rate (see Incidence)
J
K
- Kerma, K
L
- LET (see *Linear energy transfer)
- LLE (see Lifetime risk estimates)
- Loss of Life Expectancy (see Lifetime risk estimates)
- LSS (see Life Span Study)
M
- MMD (see *Mass median diameter)
N
- NHEJ (see Non-homologous end joining)
O
P
- Particle fluence (see Fluence)
- Personal dose equivalent, Hp(d)
- PLDR (see Potentially lethal damage repair)
Q
- Quality factor, Q(L)
R
- Radiation detriment (see Detriment)
- RAP (see Reference Animal and Plant)
- RBE (see Relative biological effectiveness)
- Reference female (see Reference Individual)
- Reference male (see Reference Individual)
- REID (see Lifetime risk estimates)
- Response function (see Dose-response function)
- Risk of exposure-induced death (see (see Lifetime risk estimates)
- ROS (see Reactive oxygen species)
- RR (see Relative risk)
S
- S coefficient (radiation weighted) SW[(rT←rs)]
- SAF (see Specific absorbed fraction)
- SEE (see Specific effective energy]
- Sievert (Sv)
- SLDR (see Sublethal damage repair)
- Source (see Radiation source)
T
- Transport of risk (see Transfer of risk)
U
V
W
- wT (see Tissue weighting factor)
- wR (see Radiation weighting factor)
X
Y
Z
...
- α/β ratio (see α/β value)
